Workplace productivity. A review of the impact of migraine and its treatment

Pharmacoeconomics. 2001;19(3):231-44. doi: 10.2165/00019053-200119030-00002.

Abstract

Migraine is a common disorder characterised by recurrent episodes of disability. Despite the high prevalence of migraine, data have been lacking on its impact in a working population. The advent of new therapies has stimulated interest in this area, and evidence is now available that documents the substantial impact of migraine on workplace productivity and the likelihood of untreated migraine leading to unemployment or underemployment for the patient. This paper reviews current findings of both observational and interventional studies about the impact of migraine on productivity and employment. When considered in the light of migraine demographics, the high prevalence of migraine, and its low consultation and treatment rates, this evidence indicates that improved screening and treatment for this common condition could have a substantial impact on worker productivity and on patient well-being.

Publication types

  • Review

MeSH terms

  • Cost of Illness
  • Efficiency*
  • Employment*
  • Humans
  • Migraine Disorders / drug therapy
  • Migraine Disorders / economics*